First Time Loading...

Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 134.56 USD 0.52%
Updated: Apr 18, 2024
Section:
 

Relative Value

The Relative Value of one DXCM stock under the Base Case scenario is 49.6 USD. Compared to the current market price of 134.56 USD, Dexcom Inc is Overvalued by 63%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DXCM Relative Value
Base Case
49.6 USD
Overvaluation 63%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

14.3
P/S
P/S
Price to Sales
14.3
vs History
63
vs Industry
10
Median 3Y
15.2
Median 5Y
15.2
Industry
2.4
Forward
11.8
More Details
95.8
P/E
P/E
Price to Earnings
95.8
vs History
60
vs Industry
4
Median 3Y
119.5
Median 5Y
119.5
Industry
23.4
Forward
75.4
More Details
69.5
P/OCF
P/OCF
Price to OCF
69.5
vs History
61
vs Industry
4
Median 3Y
65.3
Median 5Y
71.9
Industry
15.5
More Details
54.8
P/FCFE
P/FCFE
Price to FCFE
54.8
vs History
68
vs Industry
11
Median 3Y
148.8
Median 5Y
151.4
Industry
23.5
More Details
25.1
P/B
P/B
Price to Book Value
25.1
vs History
28
vs Industry
2
Median 3Y
20.7
Median 5Y
20.7
Industry
2.3
More Details
14.3
EV/S
EV/S
Enterprise Value to Sales
14.3
vs History
61
vs Industry
9
Median 3Y
14.9
Median 5Y
14.9
Industry
2.5
Forward
11.7
More Details
22.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
22.5
vs History
60
vs Industry
8
Median 3Y
22.8
Median 5Y
22.8
Industry
5.3
More Details
64.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
64.5
vs History
73
vs Industry
3
Median 3Y
80.8
Median 5Y
81.4
Industry
12.6
Forward
41.7
More Details
84
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
84
vs History
74
vs Industry
3
Median 3Y
113.4
Median 5Y
110.6
Industry
17.1
Forward
58.4
More Details
69.4
EV/OCF
EV/OCF
Enterprise Value to OCF
69.4
vs History
60
vs Industry
4
Median 3Y
63.6
Median 5Y
71
Industry
15
More Details
101.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
101.5
vs History
85
vs Industry
3
Median 3Y
139.6
Median 5Y
160.6
Industry
19.6
More Details
15.9
EV/IC
EV/IC
Enterprise Value to IC
15.9
vs History
76
vs Industry
4
Median 3Y
16.6
Median 5Y
21.4
Industry
2
More Details

Multiples Across Competitors

DXCM Competitors Multiples
Dexcom Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Dexcom Inc
NASDAQ:DXCM
51.9B USD 14.3 95.8 64.5 84
US
Abbott Laboratories
NYSE:ABT
182.1B USD 4.5 31.8 18.9 28
US
Intuitive Surgical Inc
NASDAQ:ISRG
131B USD 18.4 72.9 56.2 70.6
US
Stryker Corp
NYSE:SYK
125.8B USD 6.1 39.7 24.8 30.6
IE
Medtronic PLC
NYSE:MDT
104.4B USD 3.2 24.9 13.3 18.8
US
Boston Scientific Corp
NYSE:BSX
99.3B USD 7 63.3 29.5 44.1
US
Becton Dickinson and Co
NYSE:BDX
66.7B USD 3.4 54.8 18.4 38.8
DE
Siemens Healthineers AG
XETRA:SHL
57.3B EUR 2.6 37.7 18.2 30.6
US
Edwards Lifesciences Corp
NYSE:EW
52.1B USD 8.7 37.1 26.9 29.1
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
329.2B CNY 9.6 29 25.1 25.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
40B USD 10.9 47.2 33.3 36.8

See Also

Summary
DXCM intrinsic value, competitors valuation, and company profile.
DCF Valuation
DXCM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DXCM stock valuation using valuation multiples.
Wall Street Estimates
DXCM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DXCM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 129,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.